<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Mcintosh Thorhauge | Activity</title>
	<link>https://toxicdolls.com/members/sailslope4/activity/</link>
	<atom:link href="https://toxicdolls.com/members/sailslope4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Mcintosh Thorhauge.</description>
	<lastBuildDate>Thu, 14 May 2026 22:11:49 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">001a4fae85617f849ddad4180c02865c</guid>
				<title>Mcintosh Thorhauge posted an update: Patients with relapsed/refractory diffuse large B-cell [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/13551/</link>
				<pubDate>Sat, 28 Jun 2025 09:30:06 +0000</pubDate>

									<content:encoded><![CDATA[<p>Patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) have adverse outcomes. We evaluated the efficacy and safety of the phosphatidylinositol 3-kinase inhibitor copanlisib in patients with relapsed/refractory DLBCL and assessed the relationship between efficacy and DLBCL cell of origin (COO; activated B-cell like [ABC] and&hellip;<span class="activity-read-more" id="activity-read-more-13551"><a href="https://toxicdolls.com/activity-2/p/13551/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5280276de0c1b091fb4f9f2e2165fcec</guid>
				<title>Mcintosh Thorhauge posted an update: The effect of the plasma membrane on the activity of [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/11828/</link>
				<pubDate>Thu, 26 Jun 2025 09:39:40 +0000</pubDate>

									<content:encoded><![CDATA[<p>The effect of the plasma membrane on the activity of angiotensin-I converting enzyme (ACE) plays a crucial role in the evaluation of food-derived ACE inhibitory peptides, although these peptides are commonly evaluated in the system with ACE in its free state. In this study, we constructed an in vitro membrane-bound ACE C domain system to simulate&hellip;<span class="activity-read-more" id="activity-read-more-11828"><a href="https://toxicdolls.com/activity-2/p/11828/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">394ab62f0554883230903a0fa557b9e4</guid>
				<title>Mcintosh Thorhauge posted an update: In an effort to be more inclusive and embrace the [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/9137/</link>
				<pubDate>Mon, 23 Jun 2025 20:48:34 +0000</pubDate>

									<content:encoded><![CDATA[<p>In an effort to be more inclusive and embrace the international cytology community, the American Society of Cytopathology formed the International Liaison and Membership (ILM). The Worldvision Cytopathology Contest was designed by the co-chairs of this committee (Drs. Güliz A. Barkan and Esther Diana Rossi) as an opportunity of scientific&hellip;<span class="activity-read-more" id="activity-read-more-9137"><a href="https://toxicdolls.com/activity-2/p/9137/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f9498fbad74278e5e6ab09d27531b912</guid>
				<title>Mcintosh Thorhauge became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/9092/</link>
				<pubDate>Mon, 23 Jun 2025 20:21:47 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>